期刊文献+

反义TβRI对实验性大鼠肝纤维化的影响 被引量:1

Effects of antisense TβRI eukaryotic expressing plasmid on rat liver fibrosis
下载PDF
导出
摘要 目的:观察反义转化生长因子βI型受体真核表达质粒对实验性大鼠肝纤维化的影响。方法:构建大鼠反义真核细胞表达质粒,导入大鼠肝纤维化模型体内,通过Ⅰ型胶原的免疫组化以及VG染色观察两种反义质粒联合作用对大鼠肝纤维化的影响。结果:反义TβRI表达质粒可减少受损肝脏中Ⅰ型胶原的沉积(P<0.05),并可使受损肝脏的病理形态有一定改善(P<0.05)。结论:反义TβRI真核表达质粒对肝纤维化的发展有一定的干预作用。 Objective: The pedonned experiments aimed to test the hypothesis that the introduction of anfisense transfonning growth factor β receptor Ⅰ (TβRI) eukaryotie expressing plasmids into a rat model of liver fibrosis may halt the progression of liver fibrosis.Methods: The fragments of TβRI cDNA was achieved by reverse transcription polymerase chain .ration (RT- PER), and then amplified by nest PCR pcDNA3.1 ( + ) - antisense TβRI eukaryotic expressing plasmid was construct by a directional inverted joins with the purified linear pcDNA3. 1 ( + ) and the purified fragment of TβRI. Recombinant was identified by restriction endonuekease digestion and DNA sequence analysis. The recombinant plasmids were encapsulated by Lipofeetmine 2000, and then transduced into rats of liver fibrosis model via enterocoelia. The protein expression of type l collagen were evaluated by immunohistochemistry. VG staining was used for pathological diagnosis. Results: with the empty plasmid control group and disease control group, the deposition of collagens type Ⅰ decreased in anfisense TβRI group (436512.7 ± 130047.6, P 〈0.05; treatment control group 733917.7 ± 168290.8, disease control group 690236.1 ± 161333.7, normal control group 41329.7 ± 21321.9). A significant different in the pathologic grade was found between normal control group and the other three groups (P〈 0.05). A significant different in the pathologiegrade was found between disease control group and the antisense TβRI group( P〈 0.05). No difference was found in the pathologic grade between empty plasmid control group and disease control group ( P 〉 0.05). Conclusion:Antisense TβRI eukaryotic expressing plasmid could inhibit the progress of liver fibrosis.
出处 《农垦医学》 2007年第1期8-12,共5页 Journal of Nongken Medicine
基金 兵团博士资金资助项目,No.05JC08
关键词 反义 肝纤维化 转化生长因子βⅠ型受体 Antisense Liver fibrosis Transforming growth factor β receptor Ⅰ
  • 相关文献

参考文献8

  • 1Zhang L,Mi J,Yu Y,et al.IFN-gamma gene therapy by intrasplenic:hepatocyte transplantation:a novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice.Parasite Immun(o)l,2001,23 (1):11 ~17
  • 2Lewindon PJ,Pereira TN,Hoskins AC,et al.The Role of Hepatic stellate cells and transforming growth factor-β1 in cystic fibrosis liver disease.Am J Pathol,2002,160:1705 ~ 1715
  • 3Leask A,Abraham DJ.TGF-beta signaling and the fibrotic response.FASEB J,2004,18:816 ~ 827
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 5J Cárcamo,F M Weis,F Ventura,et al.Type Ⅰ receptors specify growthinhibitory and transcriptional responses to transforming growth factor beta and activin.Mol Cell Biol,1994,14:3810 ~ 3821
  • 6George J,Roulot D,Koteliansky Ve et al.In vivo inhibition of rat stellate cell activation by soluble transforming growth factor type Ⅱ receptor:A potential new therapy for hepatic fibrosis.Proc Natl Acad Sci USA,1999,96:12719 ~ 12724
  • 7汪玲,胡国龄,谭德明,刘双虎.TGF-β_1Ⅱ型受体部分基因表达质粒对实验性大鼠肝纤维化的影响[J].中华传染病杂志,2002,20(3):168-171. 被引量:23
  • 8D Roulot,AM Sevcsik,T Coste.Role of transforming growth factor beta type Ⅱ receptor in hepatic fibrosis:studies of human chronic hepatitis c and experimental fibrosis in rats.Hepatology,1999,29:1730 ~ 1738

二级参考文献2

共引文献14029

同被引文献14

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部